Transparency and accountability have become increasingly high priorities for publications of company-sponsored research. Ethical publication planning should ensure that the design and results of clinical trials and other biomedical research studies are accurately reported in a timely and transparent manner.

With these obligations in mind, these updated Good Publication Practice (GPP) guidelines are designed to guide publications of biomedical research conducted in collaboration with or sponsored by 1 or more companies. Good practice may refer to formal guidelines or generally accepted practices. The initial GPP guidelines provided ethical and other principles for publications of company-sponsored biomedical research. As new trends emerged, additional GPP iterations and Good Practice for Conference Abstracts and Presentations (GPCAP) recommendations followed to answer day to-day questions.

These updated Good Publication Practice (GPP) guidelines include recommendations for publishing company-sponsored biomedical research. The GPP guidelines apply to peer-reviewed or peer-oriented biomedical publications, such as manuscripts, meeting presentations, posters, and abstracts, as well as enhanced content, such as plain-language summaries. The current GPP guidelines incorporate guidance on ethics and transparency as well as the planning, development, review, and approval of biomedical publications and policies and procedures that describe these practices.